Description
Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to β cells of the pancreas to stimulate insulin release. Used to treat type 2 diabetes mellitus.
Nateglinide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It belongs to the meglitinide class of short-acting insulin secretagogues, which act by binding to β cells of the pancreas to stimulate insulin release. Used to treat type 2 diabetes mellitus.
Alternate Name/Synonyms: N-[[4-(1-Methylethyl)cyclohexyl]carbonyl]-D-phenylalanine
Appearance: White solid
Formulation: N/A
CAS Number: 105816-04-4
Structure Available?: Yes
Peptide sequence: N/A
Salt Form: No
Molecular Formula: C₁₉H₂₇NO₃
Molecular Weight: 317.42
Cell-Permeable?: Yes
Purity: ≥98% by HPLC
Solubilities: DMSO (~30 mg/ml)
Handling: Protect from air and light
Country of Origin: USA
Tag Line: An oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM)
MDL Number: MFCD00875706
PubChem CID: 5311309
SMILES: CC(C)C1CCC(CC1)C(=O)NC(CC2=CC=CC=C2)C(=O)O
InChi: InChI=1S/C19H27NO3/c1-13(2)15-8-10-16(11-9-15)18(21)20-17(19(22)23)12-14-6-4-3-5-7-14/h3-7,13,15-17H,8-12H2,1-2H3,(H,20,21)(H,22,23)/t15?,16?,17-/m1/s1
InChi Key: OELFLUMRDSZNSF-OFLPRAFFSA-N
Additional Information
Storage Condition: |
-20°C |
Shipping Condition: |
Gel Pack |
Shelf Life: |
36 months |